Atrial Fibrillation Type All | Exception Heart Valve Involvement | Paroxysmal atrial fibrillation | Persistent atrial fibrillation | Permanent atrial fibrillation
Item
1. patients with all types of non-valvular af (includes paroxysmal, persistent and permanent af)
boolean
C0004238 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])
C0444868 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0018826 (UMLS CUI [2,2])
C1314939 (UMLS CUI [2,3])
C0235480 (UMLS CUI [3])
C2585653 (UMLS CUI [4])
C2586056 (UMLS CUI [5])
Patient Appropriate Anticoagulation Therapy
Item
2. candidate for anticoagulation therapy
boolean
C0030705 (UMLS CUI [1,1])
C1548787 (UMLS CUI [1,2])
C0003281 (UMLS CUI [1,3])
Medical contraindication Absent Nuclear magnetic resonance imaging gadolinium-enhanced
Item
3. no contra-indication for lge-mri
boolean
C1301624 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0855566 (UMLS CUI [1,3])
Age
Item
4. patients age 18 and older
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
5. patients who are able to provide informed consent to participate in the study
boolean
C0021430 (UMLS CUI [1])
Catheter ablation for atrial fibrillation Previous
Item
1. patients who have already undergone an atrial fibrillation ablation procedure.
boolean
C2702800 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
Medical contraindication Anticoagulants
Item
2. patients with active contra-indications to any anticoagulant agent.
boolean
C1301624 (UMLS CUI [1,1])
C0003280 (UMLS CUI [1,2])
Blood Coagulation Disorders Major | Risk factors Patient Bleeding risk
Item
3. other major bleeding disorders or risk factors that would place the patient at risk of bleeding.
boolean
C0005779 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C0035648 (UMLS CUI [2,1])
C0030705 (UMLS CUI [2,2])
C3251812 (UMLS CUI [2,3])
Recent surgery
Item
4. recent surgery (within 30 days).
boolean
C2169607 (UMLS CUI [1])
Renal Insufficiency | Kidney Diseases Severe | Glomerular Filtration Rate | Medical contraindication Gadolinium
Item
5. renal insufficiency, severe kidney disorders/diseases, gfr < 30mg/dl (gadolinium contraindication).
boolean
C1565489 (UMLS CUI [1])
C0022658 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0017654 (UMLS CUI [3])
C1301624 (UMLS CUI [4,1])
C0016911 (UMLS CUI [4,2])
Liver disease Advanced
Item
6. advanced liver disease.
boolean
C0023895 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
Medical contraindication Gadolinium | Medical contraindication MRI | Artificial cardiac pacemaker
Item
7. any health related gadolinium/mri contraindications: pacemaker devices, etc.
boolean
C1301624 (UMLS CUI [1,1])
C0016911 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0024485 (UMLS CUI [2,2])
C0030163 (UMLS CUI [3])
Pregnancy | Pregnancy, Planned | Breast Feeding
Item
8. pregnant, planning to be become pregnant or nursing women
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
Informed Consent Unable
Item
9. individuals who are unable to provide informed consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Medical contraindication Pradaxa
Item
10. contraindicated for pradaxa® .
boolean
C1301624 (UMLS CUI [1,1])
C2940579 (UMLS CUI [1,2])
Study Subject Participation Status Inappropriate
Item
11. patients the investigators feel are inappropriate for the study
boolean
C2348568 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
Informed Consent Unable
Item
12. patients who cannot give informed consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])